Back to top

MacroGenics receives $10M milestone after Gilead exercises license option

MacroGenics (MGNX) announced that Gilead Sciences (GILD) has exercised its option to obtain an exclusive license for a preclinical bispecific progr...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Gilead Sciences, Inc. (GILD)

General Mills, Inc. (GIS)

MacroGenics, Inc. (MGNX)